SSTR2 and rectum neuroendocrine neoplasm: Subgroup analysis based on tumor grade showed that grade 1 rectal NET patients with SSTR2 expression had significant better overall survival than those without SSTR2 expression (5-year survival rate, 98.4% vs. 93.4%, p = 0.011; Fig. 3b).